Showing results (91-100 of 104) with videos related to

Sort By:
Pageof 11
The New England Journal of Medicine|October 5, 2022
Intermittently Scanned Continuous Glucose Monitoring for Type 1 DiabetesLalantha Leelarathna, Mark L Evans, Sankalpa Neupane, et al.
BMJ Open|April 15, 2025
Impact of real-time glucose monitoring using FreeStyle Libre 3 on glycaemia in type 2 diabetes managed with basal insulin plus SGLT2 inhibitor and/or GLP-1 agonist: the FreeDM2 randomised controlled trial protocolEmma G Wilmot, Ramzi A Ajjan, Yee S Cheah, et al.
Diabetes Research and Clinical Practice|February 28, 2024
Real-world outcomes of Omnipod DASH system use in people with type 1 diabetes: Evidence from the Association of British Clinical Diabetologists (ABCD) studyAlexandros L Liarakos, Nebras Hasan, Thomas S J Crabtree, et al.
BMJ Open|May 19, 2026
Assessing the efficacy, safety and utility of fully closed-loop insulin delivery compared to standard insulin therapy with a continuous glucose monitor in adults with type 2 diabetes (COYOTE study): a randomised parallel study protocolR Seese, C K Boughton, F T Tseung, et al.
The Lancet. Diabetes & Endocrinology|February 26, 2026
Tubeless automated insulin delivery versus multiple daily injections in children and adults with type 1 diabetes with elevated HbA1c (RADIANT): a multicentre, international, parallel-group, open-label, randomised, controlled trialEmma G Wilmot, Jacques Beltrand, Bruno Guerci, et al.
Diabetes, Obesity & Metabolism|January 26, 2026
International clinical opinion on transparency, standardisation, and calibration alignment in the performance evaluation of systems for continuous glucose monitoringJohn S Pemberton, Robert C Andrews, Katharine Barnard-Kelly, et al.
Diabetes & Metabolic Syndrome|April 26, 2022
Association of statin and/or renin-angiotensin-aldosterone system modulating therapy with mortality in adults with diabetes admitted to hospital with COVID-19: A retrospective multicentre European studySophie Harris, Yue Ruan, Sarah H Wild, et al.
Diabetes Care|August 11, 2023
Hybrid Closed-Loop Therapy in Adults With Type 1 Diabetes and Above-Target HbA1c: A Real-world Observational StudyThomas S J Crabtree, Tomás P Griffin, Yew W Yap, et al.
Diabetologia|May 9, 2021
A UK nationwide study of people with type 1 diabetes admitted to hospital with COVID-19 infectionYue Ruan, Robert E J Ryder, Parijat De, et al.
The Lancet. Diabetes & Endocrinology|April 26, 2026
Continuous glucose monitoring versus self-monitoring of blood glucose in individuals with type 2 diabetes: a randomised, multicentre, open-label, superiority trialEmma G Wilmot, Patrick Moore, Thozhukat Sathyapalan, et al.
Pageof 11